glutamic acid has been researched along with Carcinoma, Anaplastic in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (10.34) | 18.7374 |
| 1990's | 2 (6.90) | 18.2507 |
| 2000's | 1 (3.45) | 29.6817 |
| 2010's | 23 (79.31) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellvert, F; Bertero, T; Boulter, E; Bourget, I; Bozec, A; Bulavin, DV; Chan, SY; Estrach, S; Feral, CC; Gaggioli, C; Grasset, EM; Hofman, P; Meneguzzi, G; Oldham, WM; Pisano, S | 1 |
| Cheadle, JP; Harris, R; Hes, FJ; Idziaszczyk, S; Kaplan, R; Maughan, TS; Moskvina, V; Propping, P; Quirke, P; Richman, S; Seymour, M; Smith, CG; Steinke, V; West, H; Wijnen, J | 1 |
| Guan, H; Liu, R; Liu, X; Murugan, AK; Qu, S; Shan, Z; Sheng, C; Shi, X; Sun, H; Teng, W; Wang, Y; Xing, M; Yu, H; Zhu, G | 1 |
| Casadei, GP; Cesari, V; Ciarrocchi, A; Cremonini, N; de Biase, D; Gandolfi, G; Pession, A; Ragazzi, M; Sancisi, V; Tallini, G; Visani, M | 1 |
| Kang, G; Pyo, JS; Sohn, JH | 1 |
| Chmielik, E; Czarniecka, A; Handkiewicz-Junak, D; Jarzab, B; Jarzab, M; Kowal, M; Krajewska, J; Lange, D; Maciejewski, A; Oczko-Wojciechowska, M; Poltorak, S; Rusinek, D; Sacher, A; Stobiecka, E; Zebracka-Gala, J; Zembala-Nozynska, E | 1 |
| Bae, SK; Ha, TK; Jung, SJ; Kim, TH; Lee, SM; Park, JS; Urm, SH; Yoon, M | 1 |
| Choe, JH; Kim, JH; Kim, JS; Kim, SK; Lee, JH; Park, I; Woo, JW | 1 |
| Bouvet, M; Diaz-Perez, JA; Nguyen, QT; Orosco, RK; Savariar, EN; Tsien, RY; Weissbrod, PA | 1 |
| Xing, M; Zhang, T | 1 |
| Creemers, GJ; Fariña-Sarasqueta, A; Lemmens, VEPP; Moerland, E; Rutten, HJT; van den Brule, AJC; van Lijnschoten, G | 1 |
| Hodin, R; Lawler, J; Nucera, C; Parangi, S | 1 |
| Hwang, TS; Jang, YM; Kim, DL; Kim, SK; Lee, EJ; Song, KH | 1 |
| Amato, MC; Bommarito, A; Carina, V; Carissimi, E; Criscimanna, A; Di Blasi, F; Galluzzo, A; Giordano, C; Latteri, MA; Modica, G; Pitrone, M; Pizzolanti, G; Richiusa, P; Rodolico, V; Spinelli, G; Zerilli, M; Zito, G | 1 |
| Hou, P; Liu, D; Xing, M | 1 |
| Liu, D; Liu, R; Xing, M | 1 |
| Budillon, A; Campanile, E; Fenzi, G; Forno, I; Fugazzola, L; Guerra, A; Marotta, V; Moccia, T; Rossi, S; Sapio, MR; Vitale, M | 1 |
| Chung, JH; Jang, JH; Ki, CS; Kim, JW; Kim, SW; Lee, ST; Oh, YL; Shin, JH | 1 |
| Beccati, MD; Bruni, S; Buratto, M; Degli Uberti, EC; Filieri, C; Rossi, M; Rossi, R; Tagliati, F; Trasforini, G; Zatelli, MC | 1 |
| Cameselle-Teijeiro, JM; Couto, JP; Faustino, A; Lopes, JM; Pardal, F; Pópulo, H; Rocha, AS; Soares, P; Sobrinho-Simões, M | 1 |
| Lee, KC; Li, C; Schneider, EB; Zeiger, MA | 1 |
| Agate, L; Basolo, F; Biagini, A; Elisei, R; Giannini, R; Lupi, C; Materazzi, G; Miccoli, P; Molinaro, E; Piaggi, P; Pinchera, A; Romei, C; Torregrossa, L; Ugolini, C; Valerio, L; Viola, D; Vitti, P | 1 |
| Caleo, A; Deandrea, M; Esposito, S; Fulciniti, F; Guerra, A; Limone, PP; Marotta, V; Motta, M; Vitale, M; Zeppa, P | 1 |
| ALFORD, MA; BROTMAN, M; CHUDY, MA; FRASER, MJ | 1 |
| CRAVEN, S; FU, SC; TERZIAN, H | 1 |
| DESPOPOULOS, A; HEINZ, E; LOEWE, U; PFEIFFER, B | 1 |
| Hirokawa, M; Ito, Y; Miyauchi, A; Takano, T; Yoshida, H | 1 |
| Kang, YJ | 1 |
| Berns, CM; Chen, JC; Corry, PM; Davis, BH; Galoforo, SS; Lee, YJ; Sim, JE; Spitz, DR | 1 |
3 review(s) available for glutamic acid and Carcinoma, Anaplastic
| Article | Year |
|---|---|
BRAF Immunohistochemistry Using Clone VE1 is Strongly Concordant with BRAF(V600E) Mutation Test in Papillary Thyroid Carcinoma.
Topics: Amino Acid Substitution; Carcinoma; Carcinoma, Papillary; Cloning, Molecular; DNA Mutational Analysis; Glutamic Acid; Humans; Immunohistochemistry; Molecular Diagnostic Techniques; Mutation, Missense; Proto-Oncogene Proteins B-raf; Reproducibility of Results; Sensitivity and Specificity; Thyroid Cancer, Papillary; Thyroid Neoplasms; Valine | 2015 |
The BRAFV600E mutation: what is it really orchestrating in thyroid cancer?
Topics: Amino Acid Substitution; Biomarkers, Tumor; Carcinoma; Carcinoma, Papillary; Cell Transformation, Neoplastic; Glutamic Acid; Humans; Models, Biological; Mutation, Missense; Proto-Oncogene Proteins B-raf; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Valine | 2010 |
BRAF V600E mutation and its association with clinicopathological features of papillary thyroid cancer: a meta-analysis.
Topics: Age Factors; Amino Acid Substitution; Carcinoma; Carcinoma, Papillary; Female; Genetic Association Studies; Genetic Predisposition to Disease; Glutamic Acid; Humans; Lymphatic Metastasis; Male; Mutation, Missense; Proto-Oncogene Proteins B-raf; Sex Characteristics; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tumor Burden; Valine | 2012 |
1 trial(s) available for glutamic acid and Carcinoma, Anaplastic
| Article | Year |
|---|---|
The BRAF(V600E) mutation is associated with malignant ultrasonographic features in thyroid nodules.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Biopsy, Fine-Needle; Carcinoma; Carcinoma, Papillary; Diagnosis, Differential; DNA Mutational Analysis; Female; Genetic Predisposition to Disease; Glutamic Acid; Humans; Male; Middle Aged; Mutation; Proto-Oncogene Proteins B-raf; Sensitivity and Specificity; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroid Nodule; Ultrasonography; Valine; Young Adult | 2011 |
25 other study(ies) available for glutamic acid and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Tumor-Stroma Mechanics Coordinate Amino Acid Availability to Sustain Tumor Growth and Malignancy.
Topics: Adaptor Proteins, Signal Transducing; Animals; Aspartic Acid; Breast Neoplasms; Cancer-Associated Fibroblasts; Carcinoma; Cell Line; Extracellular Matrix; Female; Glutamic Acid; Head and Neck Neoplasms; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Trans-Activators; Transcription Factors; Transcriptional Coactivator with PDZ-Binding Motif Proteins; YAP-Signaling Proteins | 2019 |
Role of the oxidative DNA damage repair gene OGG1 in colorectal tumorigenesis.
Topics: Adenoma; Adult; Aged; Aged, 80 and over; Alleles; Carcinoma; Case-Control Studies; Colorectal Neoplasms; DNA Damage; DNA Glycosylases; DNA Repair; Female; Gene Expression Regulation, Neoplastic; Glutamic Acid; Glycine; Humans; Male; Middle Aged; Mutation; Odds Ratio; Oxidation-Reduction; Penetrance; Up-Regulation | 2013 |
TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Amino Acid Substitution; Base Sequence; Carcinoma; Carcinoma, Papillary; Cohort Studies; Female; Gene Frequency; Genetic Association Studies; Glutamic Acid; Humans; Male; Middle Aged; Molecular Sequence Data; Mutation; Neoplasm Invasiveness; Promoter Regions, Genetic; Proto-Oncogene Proteins B-raf; Telomerase; Thyroid Cancer, Papillary; Thyroid Neoplasms; Valine | 2014 |
High-sensitivity BRAF mutation analysis: BRAF V600E is acquired early during tumor development but is heterogeneously distributed in a subset of papillary thyroid carcinomas.
Topics: Adult; Aged; Amino Acid Substitution; Carcinoma; Carcinoma, Papillary; Cell Transformation, Neoplastic; DNA Mutational Analysis; Gene Frequency; Genetic Heterogeneity; Glutamic Acid; Humans; Middle Aged; Polymerase Chain Reaction; Proto-Oncogene Proteins B-raf; Thyroid Cancer, Papillary; Thyroid Neoplasms; Valine; Young Adult | 2014 |
The Risk of Relapse in Papillary Thyroid Cancer (PTC) in the Context of BRAFV600E Mutation Status and Other Prognostic Factors.
Topics: Adult; Amino Acid Substitution; Biomarkers, Tumor; Carcinoma; Carcinoma, Papillary; Female; Gene Frequency; Glutamic Acid; Humans; Male; Middle Aged; Mutation, Missense; Predictive Value of Tests; Prognosis; Proto-Oncogene Proteins B-raf; Recurrence; Risk Factors; Thyroid Cancer, Papillary; Thyroid Neoplasms; Valine | 2015 |
Relationships between transporter expression and the status of BRAF V600E mutation and F-18 FDG uptake in papillary thyroid carcinomas.
Topics: Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glucose Transporter Type 3; Glutamic Acid; Humans; Immunohistochemistry; Male; Middle Aged; Mutation, Missense; Positron-Emission Tomography; Proto-Oncogene Proteins B-raf; Retrospective Studies; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, Emission-Computed; Valine; Young Adult | 2016 |
Chronic lymphocytic thyroiditis and BRAF V600E in papillary thyroid carcinoma.
Topics: Adult; Amino Acid Substitution; Carcinoma; Carcinoma, Papillary; Female; Glutamic Acid; Hashimoto Disease; Humans; Lymphatic Metastasis; Male; Middle Aged; Mutation, Missense; Prognosis; Proto-Oncogene Proteins B-raf; Retrospective Studies; Thyroid Cancer, Papillary; Thyroid Neoplasms; Valine | 2016 |
Molecular targeting of papillary thyroid carcinoma with fluorescently labeled ratiometric activatable cell penetrating peptides in a transgenic murine model.
Topics: Animals; Animals, Genetically Modified; Carcinoma; Carcinoma, Papillary; Cell-Penetrating Peptides; Disease Models, Animal; Fluorescence; Glutamic Acid; Laryngoscopy; Larynx; Mice; Molecular Targeted Therapy; Proto-Oncogene Proteins B-raf; Staining and Labeling; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy; Treatment Outcome; Valine; Video Recording; Vocal Cords | 2016 |
HABP2 G534E Mutation in Familial Nonmedullary Thyroid Cancer.
Topics: Adult; Aged; Carcinoma; Carcinoma, Papillary; Female; Genetic Predisposition to Disease; Germ-Line Mutation; Glutamic Acid; Glycine; Humans; Male; Middle Aged; Prevalence; Serine Endopeptidases; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2016 |
The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Carcinoma; Colonic Neoplasms; Female; Genes, ras; Glutamic Acid; Humans; Male; Microsatellite Instability; Middle Aged; Mutation, Missense; Neoplasm Staging; Prognosis; Proto-Oncogene Proteins B-raf; Survival Analysis; Valine | 2010 |
BRAFV600E mutation, TIMP-1 upregulation, and NF-κB activation: closing the loop on the papillary thyroid cancer trilogy.
Topics: Adult; Amino Acid Substitution; Carcinoma; Carcinoma, Papillary; Cell Transformation, Neoplastic; Disease Progression; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Glutamic Acid; Humans; Male; Middle Aged; Mutation, Missense; Neoplasm Invasiveness; NF-kappa B; Proto-Oncogene Proteins B-raf; Signal Transduction; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tissue Inhibitor of Metalloproteinase-1; Tumor Cells, Cultured; Up-Regulation; Valine | 2011 |
Genome-wide alterations in gene methylation by the BRAF V600E mutation in papillary thyroid cancer cells.
Topics: Amino Acid Substitution; Carcinoma; Carcinoma, Papillary; Cluster Analysis; CpG Islands; DNA Methylation; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Genome, Human; Glutamic Acid; Humans; Microarray Analysis; Mutation, Missense; Proto-Oncogene Proteins B-raf; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tumor Cells, Cultured; Valine | 2011 |
The Akt inhibitor MK2206 synergizes, but perifosine antagonizes, the BRAF(V600E) inhibitor PLX4032 and the MEK1/2 inhibitor AZD6244 in the inhibition of thyroid cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Carcinoma; Cell Proliferation; Down-Regulation; Drug Antagonism; Drug Evaluation, Preclinical; Drug Synergism; Glutamic Acid; Heterocyclic Compounds, 3-Ring; Humans; Indoles; Mutant Proteins; Oncogene Protein v-akt; Phosphorylcholine; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Sulfonamides; Thyroid Neoplasms; Tumor Cells, Cultured; Valine; Vemurafenib | 2012 |
The primary occurrence of BRAF(V600E) is a rare clonal event in papillary thyroid carcinoma.
Topics: Amino Acid Substitution; Base Sequence; Carcinoma; Carcinoma, Papillary; Clone Cells; DNA Mutational Analysis; Gene Frequency; Glutamic Acid; Humans; Mutation, Missense; Proto-Oncogene Proteins B-raf; Retrospective Studies; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tumor Cells, Cultured; Valine | 2012 |
Clinical implication of highly sensitive detection of the BRAF V600E mutation in fine-needle aspirations of thyroid nodules: a comparative analysis of three molecular assays in 4585 consecutive cases in a BRAF V600E mutation-prevalent area.
Topics: Adult; Amino Acid Substitution; Biopsy, Fine-Needle; Carcinoma; Carcinoma, Papillary; Cohort Studies; Cytological Techniques; DNA Mutational Analysis; Female; Gene Frequency; Glutamic Acid; Humans; Male; Middle Aged; Molecular Diagnostic Techniques; Mutation, Missense; Prevalence; Proto-Oncogene Proteins B-raf; Sensitivity and Specificity; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroid Nodule; Valine | 2012 |
Role of ultrasonographic/clinical profile, cytology, and BRAF V600E mutation evaluation in thyroid nodule screening for malignancy: a prospective study.
Topics: Adult; Amino Acid Substitution; Biopsy, Fine-Needle; Carcinoma; Carcinoma, Papillary; Cytological Techniques; DNA Mutational Analysis; Early Detection of Cancer; Female; Glutamic Acid; Humans; Male; Middle Aged; Molecular Diagnostic Techniques; Mutation, Missense; Predictive Value of Tests; Prospective Studies; Proto-Oncogene Proteins B-raf; Retrospective Studies; Sensitivity and Specificity; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroid Nodule; Ultrasonography, Interventional; Valine | 2012 |
mTOR pathway overactivation in BRAF mutated papillary thyroid carcinoma.
Topics: Amino Acid Substitution; Carcinoma; Carcinoma, Papillary; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Glutamic Acid; HEK293 Cells; Humans; Mutation, Missense; Proto-Oncogene Proteins B-raf; Serine; Signal Transduction; Thyroid Cancer, Papillary; Thyroid Neoplasms; TOR Serine-Threonine Kinases; Transfection; Up-Regulation; Valine | 2012 |
The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Carcinoma; Carcinoma, Papillary; Cohort Studies; Female; Genetic Predisposition to Disease; Glutamic Acid; Humans; Male; Middle Aged; Mutation, Missense; Prognosis; Proto-Oncogene Proteins B-raf; Risk Factors; Sample Size; Thyroid Cancer, Papillary; Thyroid Gland; Thyroid Neoplasms; Valine; Young Adult | 2012 |
BRAF (V600E) associates with cytoplasmatic localization of p27kip1 and higher cytokeratin 19 expression in papillary thyroid carcinoma.
Topics: Amino Acid Substitution; Carcinoma; Carcinoma, Papillary; Cyclin-Dependent Kinase Inhibitor p27; Cytoplasm; Galectin 3; Gene Expression Regulation, Neoplastic; Gene Frequency; Glutamic Acid; Humans; Immunohistochemistry; Keratin-19; Proto-Oncogene Proteins B-raf; Thyroid Cancer, Papillary; Thyroid Neoplasms; Valine | 2013 |
The activation of glutamic acid and glutamine in mammalian tissues.
Topics: Animals; Carcinoma; Carcinoma, Ehrlich Tumor; Glutamates; Glutamic Acid; Glutamine; Ligases; Liver; Mammals | 1963 |
SYNTHESIS AND BIOLOGICAL ACTIVITY OF ISOMERS OF N-(BIS(2-CHLOROETHYL)AMINOBENZOYL)GLUTAMIC ACID.
Topics: Animals; Bacteria; Carcinoma; Carcinoma, Ehrlich Tumor; Chemistry, Pharmaceutical; Glutamates; Glutamic Acid; Mice; Nitrogen Mustard Compounds; Pharmacology; Research; Tissue Culture Techniques | 1964 |
TRANSPORT AND METABOLISM OF GLUTAMATE IN EHRLICH ASCITES CARCINOMA CELLS.
Topics: Amino Acids; Animals; Ascites; Biological Transport; Carcinoma; Carcinoma, Ehrlich Tumor; Dinitrophenols; Glutamates; Glutamic Acid; Iodoacetates; Mice; Ouabain; Research; Thiourea | 1964 |
BRAF V600E mutation in anaplastic thyroid carcinomas and their accompanying differentiated carcinomas.
Topics: Adult; Aged; Aged, 80 and over; Base Sequence; Carcinoma; Disease Progression; DNA Mutational Analysis; Female; Gene Frequency; Glutamic Acid; Humans; Male; Middle Aged; Models, Biological; Mutation, Missense; Proto-Oncogene Proteins B-raf; Thyroid Neoplasms; Valine | 2007 |
Buthionine sulfoximine enhances glutathione-but attenuates glutamate-stimulated cell proliferation.
Topics: Antimetabolites, Antineoplastic; Buthionine Sulfoximine; Carcinoma; Cell Division; Culture Media; Enzyme Inhibitors; Glutamic Acid; Glutathione; Humans; Lung Neoplasms; Methionine Sulfoximine; Tumor Cells, Cultured | 1995 |
Glucose deprivation-induced cytotoxicity and alterations in mitogen-activated protein kinase activation are mediated by oxidative stress in multidrug-resistant human breast carcinoma cells.
Topics: Acetylcysteine; Breast Neoplasms; Carcinoma; Cell Death; Drug Resistance, Multiple; Enzyme Activation; Female; Glucose; Glutamic Acid; Glutamine; Glutathione; Glutathione Disulfide; Humans; Mitogen-Activated Protein Kinase 1; Oxidative Stress; Signal Transduction; Tumor Cells, Cultured | 1998 |